Tianjing Li

Biographic Data

ID6063745
NAMETianjing Li
GIVEN NAMESTianjing
FAMILY NAMELi
SIGNATURELI T
AFFILIATIONSJohns Hopkins University
ORCID0009-0009-5554-1721
VERIFIEDYes
TOTAL WORKS15
TOTAL CITATIONS0
WORKS AS AUTHOR14
WORKS AS EDITOR1
FIRST PUBLICATION YEAR2019
LATEST PUBLICATION YEAR2025
H-INDEX0

  • Transfer Learning for Dynamic Community Knowledge Detection Based on Dual-Population Cooperation and Competition

    Open AccessYan Kang, Baochen Fan et al.ARTICLEIEEE Transactions on Computational…2025

    Extracting evolving communities in social networks has attracted much attention recently due to its usefulness in the area of social media. Most existing models assume that network structures evolve monotonically and fail to leverage the fluctuating variation in the real world. Moreover, it is difficult to extract valuable community knowledge from previous snapshots, leading to a negative transfer to the current snapshot. In this article, we desi…

  • Enhancing Methodological Approaches for Studying Health Effects of High-Concentration THC Products

    Tianjing Li, George Sam Wang et al.ARTICLEAmerican Journal of Public Health2024References: 13

    For public health protection, informed decision-making relies on having a robust foundation of evidence concerning risks and their prevention. Application of an evidence-based framework depends on the availability of pertinent, scientifically sound data generated by well-directed and valid research endeavors. In this essay, we address the current state of research in humans and the evidential base concerning high-concentration delta-9-tetrahydroc…

  • Health Effects of High-Concentration Cannabis Products

    Lisa Bero, Rosa Lawrence et al.ARTICLEAmerican Journal of Public Health2023

    Background. The concentration of pharmacologically active tetrahydrocannabinol (THC) in cannabis products has been increasing over the past decade. Concerns about potential harmful health effects of using these increasingly higher-concentration products have led some states to consider regulation of cannabis product THC concentration. We conducted a scoping review of health effects of high-concentration cannabis products to inform policy on wheth…

  • A declaração PRISMA 2020

    Open AccessMatthew J Page, Joanne E McKenzie et al.ARTICLERevista Panamericana de Salud…2022

    A declaração dos Principais Itens para Relatar Revisões Sistemáticas e Meta-análises (PRISMA), publicada em 2009, foi desenvolvida para ajudar revisores sistemáticos a relatar de forma transparente por que a revisão foi feita, os métodos empregados e o que os autores encontraram. Na última década, os avanços na metodologia e terminologia de revisões sistemáticas exigiram a atualização da diretriz. A declaração PRISMA 2020 substitui a declaração d…

  • The PRISMA 2020 statement

    Open AccessMatthew J Page, Joanne E McKenzie et al.ARTICLEPLoS Medicine2021

  • The PRISMA 2020 statement

    Open AccessMatthew J Page, Joanne E McKenzie et al.ARTICLEJournal of Clinical Epidemiology2021

  • Declaración PRISMA 2020

    Open AccessMatthew J Page, Joanne E McKenzie et al.ARTICLERevista Española de Cardiología…2021

    La declaración PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses), publicada en 2009, se diseñó para ayudar a los autores de revisiones sistemáticas a documentar de manera transparente el porqué de la revisión, qué hicieron los autores y qué encontraron. Durante la última década, ha habido muchos avances en la metodología y terminología de las revisiones sistemáticas, lo que ha requerido una actualización de esta guía. La…

  • The PRISMA 2020 statement

    Open AccessMatthew J Page, Joanne E McKenzie et al.ARTICLEInternational Journal of Surgery2021

  • PRISMA 2020 explanation and elaboration

    Open AccessMatthew J Page, David Moher et al.ARTICLEBMJ2021

  • The PRISMA 2020 statement

    Open AccessMatthew J Page, Joanne E McKenzie et al.ARTICLEBMJ2021

  • The PRISMA 2020 statement

    Open AccessMatthew J Page, Joanne E McKenzie et al.ARTICLESystematic Reviews2021

  • The PRISMA 2020 statement

    Matthew J Page, Joanne Mckenzie et al.PREPRINT2020

    Background: The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did and what they found. Over the last decade, there have been many advances in systematic review methodology and terminology, which have necessitated an update to the guideline.Objectives: To develop the PRISMA 2020 statem…

  • Cochrane Handbook for Systematic Reviews of Interventions

    Open AccessFarhad Shokraneh, Carol Lefebvre et al.EDITORBOOKCochrane Handbook for Systematic…2019

    The revised edition of the Handbook offers the only guide on how to conduct, report and maintain a Cochrane Review The second edition of The Cochrane Handbook for Systematic Reviews of Interventions contains essential guidance for preparing and maintaining Cochrane Reviews of the effects of health interventions. Designed to be an accessible resource, the Handbook will also be of interest to anyone undertaking systematic reviews of interventions o…

  • RoB 2

    Open AccessJonathan Sterne, Jelena Savović et al.ARTICLEBMJ2019

    Assessment of risk of bias is regarded as an essential component of a systematic review on the effects of an intervention. The most commonly used tool for randomised trials is the Cochrane risk-of-bias tool. We updated the tool to respond to developments in understanding how bias arises in randomised trials, and to address user feedback on and limitations of the original tool.

  • Updated guidance for trusted systematic reviews

    Miranda Cumpston, Tianjing Li et al.ARTICLECochrane Database of Systematic…2019